Facilitated By

San Antonio Medical Foundation

News

  • The $170B Survival Race: Why Big Pharma is Snapping Up Late-Stage Cancer Tech

    Clinical-stage biotech company Oncolytics Biotech Inc. (NASDAQ ... San Antonio Breast Cancer Symposium, demonstrating compelling efficacy ...

  • San Antonio names new director to lead Public Works Department | TPR

    Bioscience-Medicine · Border ... Reinhardt said he was looking forward to getting to work to "better serve the people of San Antonio.".

  • How $594B in Precision Tech is Cracking the Metastatic Cancer Code | INN

    Clinical-stage biotech company Oncolytics Biotech Inc. ... Kazia Therapeutics Limited (NASDAQ: KZIA) presented new data at the 2025 San Antonio ...

  • CCNY undergrads produce five-star performance at annual national STEM conference

    ... Biomedical Research Conference for Minoritized Scientists (ABRCMS) in San Antonio, Texas. The conference attracted close to 5000 participants ...

  • Positive Kisqali data will help Novartis take the fight to Pfizer - The Pharma Letter

    More on this story... Novartis expands in gene therapy and neuroscience with $8.7 billion ...